Solventum
Prezzo: 78.87Società e modello di business
Solventum operates in the healthcare sector, focusing on the development and commercialization of innovative medical solutions. Its core products include advanced therapeutic devices and diagnostic tools aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers and institutions. Solventum's business segments encompass research and development, manufacturing, and distribution of healthcare technologies.
Profilo di investimento
The investment profile of Solventum is more aligned with growth investors, given its focus on innovation and potential for revenue expansion. The company shows stable earnings growth and a moderate risk profile, appealing to those seeking capital appreciation. Its performance metrics suggest a favorable outlook for long-term investment strategies.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 8.21 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 0.5% ≈
- Sorpresa EPS
- 9.6% meglio del previsto
- Volatilità 20g
- 2.1% stabile
Impatto della previsione
esauritoTraccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-10 00:49 | Mantieni | Compra | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-06-09 02:51 | Compra | Mantieni | Mixed performance and uncertain market conditions. |
| 2026-06-05 02:48 | Mantieni | Compra | Strong momentum and solid EPS growth support bullish outlook. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-06-01 11:15 | Jefferies | Target alzato | — → 43 | 74.95 |
| 2026-05-15 11:13 | Wedbush | Aggiorna | — → 94 | 74.42 |
| 2026-05-06 13:34 | UBS | Target abbassato | 82 → 78 | 71.355 |
Ancora nulla